MKSI:NGS-MKS Instruments Inc. (USD)

EQUITY | Scientific & Technical Instruments | Nasdaq Global Select

Last Closing

USD 130.58

Change

+0.50 (+0.38)%

Market Cap

USD 3.08B

Volume

1.19M

Analyst Target

USD 148.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

MKS Instruments Inc is engaged in providing instruments, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of manufacturing processes to improve process performance and productivity.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
TRMB Trimble Inc

N/A

USD 15.06B
CGNX Cognex Corporation

N/A

USD 6.91B
NOVT Novanta Inc

N/A

USD 6.34B
ITRI Itron Inc

N/A

USD 4.82B
MLAB Mesa Laboratories Inc

N/A

USD 0.69B
ITRN Ituran Location and Control Lt..

N/A

USD 0.53B
FARO FARO Technologies Inc

N/A

USD 0.37B
MVIS Microvision Inc

N/A

USD 0.25B
LUNA Luna Innovations Incorporated

N/A

USD 0.08B
SOTK Sono-Tek Corp

N/A

USD 0.06B

ETFs Containing MKSI

LADR:XETRA L&G Optical Technology & .. 3.87 % 0.00 %

N/A

N/A
FKU First Trust United Kingdo.. 2.80 % 0.80 %

N/A

USD 0.08B
FKU:LSE First Trust United Kingdo.. 2.76 % 0.00 %

N/A

USD 7.46M
FKUD:LSE First Trust United Kingdo.. 2.76 % 0.00 %

N/A

USD 2.64M
CUKS:LSE iShares VII PLC - iShares.. 2.24 % 0.00 %

N/A

USD 0.17B
IMOM Alpha Architect Internati.. 2.11 % 0.00 %

N/A

N/A
SXRD:F iShares VII Public Limite.. 2.08 % 0.00 %

N/A

USD 0.17B
SXRD:XETRA iShares VII PLC - iShares.. 2.08 % 0.00 %

N/A

USD 0.18B
CSUKS:SW iShares VII PLC - iShares.. 2.08 % 0.00 %

N/A

USD 0.17B
AVDV Avantis® International S.. 1.33 % 0.00 %

N/A

USD 6.78B
ZPRX:F SSgA SPDR ETFs Europe II .. 0.80 % 0.00 %

N/A

USD 0.25B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.80 % 0.00 %

N/A

USD 0.17B
CEM:PA Amundi MSCI Europe Small .. 0.75 % 0.00 %

N/A

USD 0.15B
X026:XETRA Amundi MSCI Europe Small .. 0.75 % 0.00 %

N/A

USD 0.11B
SMC:PA SPDR MSCI Europe Small Ca.. 0.67 % 0.00 %

N/A

USD 0.25B
SMCX:SW SPDR® MSCI Europe Small .. 0.67 % 0.00 %

N/A

USD 0.25B
SIZ 0.63 % 1.71 %

N/A

N/A
RTLA 0.00 % 0.00 %

N/A

N/A
SCAP Series Portfolios Trust 0.00 % 0.90 %

N/A

N/A
TWOK 0.00 % 0.10 %

N/A

N/A
XXSC:LSE db x-trackers MSCI Europe.. 0.00 % 0.00 %

N/A

USD 2.03B
HMCX:PA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.94% 91% A- 86% B+
Dividend Return 0.43% 100% F 14% F
Total Return 27.36% 91% A- 86% B+
Trailing 12 Months  
Capital Gain 20.80% 91% A- 79% B-
Dividend Return 0.81% 75% C 12% F
Total Return 21.61% 91% A- 78% C+
Trailing 5 Years  
Capital Gain 67.65% 93% A 79% B-
Dividend Return 5.47% 50% F 18% F
Total Return 73.12% 100% F 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.33% 78% C+ 67% D+
Dividend Return 10.07% 78% C+ 66% D+
Total Return 0.75% 50% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 40.76% 61% D- 44% F
Risk Adjusted Return 24.72% 83% B 60% D-
Market Capitalization 3.08B 95% A 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Scientific & Technical Instruments) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.30 64% 25%
Price/Book Ratio 3.33 47% 32%
Price / Cash Flow Ratio 29.73 37% 9%
Price/Free Cash Flow Ratio -10.53 95% 84%
Management Effectiveness  
Return on Equity -51.90% 52% 31%
Return on Invested Capital -17.60% 43% 35%
Return on Assets 3.10% 77% 79%
Debt to Equity Ratio 189.97% 13% 11%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector